Protective effect of lycopene in cardiovascular disease

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 3, 2008, Pages 183-190

  Riccioni, Graziano ^a,b   Mancini, B ^b   Di Ilio, E ^b   Bucciarelli, T ^b   D'Orazio, N ^b  

^a SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerosis; Cardiovascular risk; Lycopene; Oxidized LDL; Vita ruins

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; LOW DENSITY LIPOPROTEIN; LYCOPENE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; RETINOL;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIETARY INTAKE; DRUG EFFECT; EPIDEMIOLOGICAL DATA; HEART PROTECTION; HUMAN; INCIDENCE; LIPID OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PHYTOCHEMISTRY; REVIEW; SOCIAL ASPECT; WESTERN HEMISPHERE;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CAROTENOIDS; DIETARY SUPPLEMENTS; HUMANS; OXIDATIVE STRESS;

EID: 48149099938     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. PEARSON TA. Cardiovascular disease in developing countries: Myths, realities, and opportunities. Cardiovasc Drug Ther 1999; 13: 95-104.
2. VASAN RS, BENJAMIN EJ, SULLIVAN LM, D'AGOSTINO RB. The burden of increasing worldwide cardiovascular disease. In: Hurst's, The Heart, Fuster C, Wayne AR, O'Rourke RA (eds), 11th edition, New York, McGraw-Hill, 2004.
3. NEATON J, WENTWORTH D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and difference by age for 316.099 white man. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152: 56-64.
4. RAO AV, RAO GL. Carotenoid and human health. Pharmacol Res 2007; 55: 207-216.
5. KHAN N, AFAQ F, MUKHTAR H. Cancer chemoprevention through dietary antioxidants: Progress and promise. Antioxid Redox Signal 2008; 10: 475-510.
6. GIOVANNUCCI E. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J Natl Cancer Inst 1999; 91: 317-31.
7. SEREN S, LIEBERMAN R, BAYRAKTAR UD, HEATH E, SAHIN K, ANDIC F, KUCUK O. Lycopene in cancer prevention and treatment. Am J Ther 2008; 15: 66-81.
8. BRITTON G. Structure and properties of carotenoids in relation to function. FASEB J 1995; 9: 1551-1558.
9. RICCIONI G, BUCCIARELLI T, MANCINI B, DI IUO C, CAPRA V, D'ORAZIO N. The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert Opin Investig Drugs 2007; 16: 25-32.
10. RICCIONI G, BUCCIARELLI T, MANCINI B, CORRADI F, DI ILIO C, MATTEI P, D'ORAZIO N. Antioxidant vitamin supplementation in cardiovascular diseases. Ann Clin Lab Sci 2007; 37: 89-95.
11. RAO AV, RAY MR, RAO LG. Lycopene. Adv Food Nutr Res 2006; 51: 99-164.
12. DZAU VJ, ANTMAN EM, BLACK HR, HAYES DL, MANSON JAE, PLUTZY J. The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes. Part I: Pathophysiology and clinical trial evidence (Risk factors through stable coronary artery disease). Circulation 2006; 114: 2850-2870.
13. DZAU J. Theodore Cooper lecture: Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis. Hypertension 2001; 37: 1047-1052.
14. AMES BN, GOLD LS, WILLETT WC. Causes and prevention of cancer. Proc Natl Acad Sci USA 1995; 92: 5258-5265.
15. WITZTUM JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
16. HALLIWELL B. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 1994; 344: 721-724.
17. HELLER FR, DESCAMPS O, HONDEKUN JC. LDL oxidation: Therapeutic perspectives. Atherosclerosis 1998; 137 (Suppl): S25-S31.
18. ROSENFELD ME. Leukocyte recruitment into developing atherosclerotic lesion: The complex interaction between multiple molecules keeps getting more complex. Arterioscl Thromb Vasc Biol 2002; 22: 361-363.
19. BAGGIOLINI M. Chemokines in pathology and medicine. J Intern Med 2001; 250: 91-104.
20. CALABRO P, WILERSON JT, YEH ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108:1930-1932.
21. JABS WJ, THEISSING E, NITSCHKE M, BECHTEL JF, DUCHROW M, MOHAMED S, JAHRBECK B, SIEVERS HH, STEINHOFF J, BARTELS C. Local generation of C-reactive protein in diseased coronary artery venous by pass grafts and normal vascular tissue. Circulation 2003; 108: 1428-1431.
22. ZWAKA TP, HOMBACH V, TORZEWSKI J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis. Circulation 2001; 103: 1194-1197.
23. ALBERT CM, MA J, RIFAI N, STAMPFER MJ, RIDKER PM. Prospective study of CRP, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105: 2595-2599.
24. RIDKER PM, CUSHMAN M, RIFAI N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral artery disease. JAMA 2001; 285: 2481-2485.
25. BURKE AP, TRACY RP, KOLODGIE F. MALCOM GT, ZIESKE A, KUTYS R, PESTANER J, SMIALEK J, VIRMANI R. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies. Circulation 2002; 105: 2019-2023.
26. CANADA'S FOOD GUIDE TO HEALTHY EATING. Ottawa: Health Canada; 1992. Cat no H3953/1992E. Available: www.hcc.gc.ca/hppb/nutrition/pube/ foodguid/foodguide.html.
27. DIETARY GUIDELINES FOR AMERICANS. 5th ed. Home and Garden Bulletin no 232. Washington: US Department of Agriculture, US Department of Health and Human Services; 2000. Available: www.nal.usda.gov/fnic/dga.
28. HALLIWELL B, MURCIA MA, CHIRICO S, ARUOMA OI. Free radicals and antioxidants in food and in vivo: What they do and how they work. Crit Rev Food Sci Nutr 1995; 35: 7-20.
29. SIES H, STAHL W. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995; 62: 1315S-1321S.
30. FERI B. Natural antioxidants in human health and disease. San Diego: Academic Press; 1994.
31. FOOD, NUTRITION AND THE PREVENTION OF CANCER: A GLOBAL PERSPECTIVE. Washington: World Cancer Research Fund/American Institute for Cancer Research; 1997.
32. RIMM EB, STAMPFER MJ, ASCHERIO A, GIOVANNUCCI E, COLDITZ G-A, WILLETT W-C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-1456.
33. GAZIANO JM, MANSON JE, BRANCH LG, COLDITZ GA, WILLETT WC, BURING JE. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995; 5: 255-260.
34. RAO AV, AGARWAL S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: A review. Nutr Res 1999; 19: 305-323.
35. CLINTON SK. Lycopene: Chemistry, biology, and implications for human health and disease. Nutr Rev 1998; 56: 35-51.
36. ZECHMEISTER L, LEROSEN AL, WENT FW, PAULING L. Prolycopene, a naturally occurring stereoisomer of lycopene. Proc Natl Acad Sci USA 1991; 21: 468-474.
37. CLINTON SK, EMENHISER C, SCHWARTZ SJ, BOSTWICK DG, WILLIAMS AW, MOORE BJ. Cis-trans Lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996; 5: 823-833.
38. MILLER NJ, SAMPSON J, CANDEIAS LP, BRAMLEY PM, RICE-EVANS CA. Antioxidant activities of carotenes and xanthophylls. FEBS Lett 1996; 384: 240-246.
39. MORTENSEN A, SKIBSTED LH. Relative stability of carotenoid radical cations and homologue tocopheroxyl radicals. A real time kinetic study of antioxidant hierarchy. FEBS Lett 1997; 417: 261-266.
40. WOODALL AA, LEE SWM, WEESIE RJ, JACKSON MJ, BRITTON G. Oxidation of carotenoids by free radicals: Relationship between structure and reactivity. Biochim Biophys Acta 1997; 1336: 33-42.
41. DI MASCIO P, KAISER S, SIES H. Lycopene as the most effective biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274: 532-538.
42. STAHL W, SCHWARZ W, SUNDQUIST AR, SIES H. Cistrans isomers of lycopene and beta-carotene in human serum and tissues. Arch Biochem Biophys 1992; 294: 173-177.
43. KAPLAN LA, LAU JM, STEIN EA. Carotenoid composition, concentrations and relationships in various human organs. Clin Physiol Biochem 1990; 8: 1-10.
44. SCHMITZ HH, POOR CL, WELLMAN RB, ERDMAN JW Jr. Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J Nutr 1991; 121: 1613-1621.
45. NIERENBERG DW, NANN SL. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am J Clin Nutr 1992; 56: 417-426.
46. MICHAUD DS, GIOVANNUCCI EL, ASCHERIO A, RIMM EB, FORMAN MR, SAMPSON L. Associations of plasma carotenoid concentrations and dietary intake of specific carotenoids in samples of two prospective cohort studies using a new carotenoid database. Cancer Epidemiol Biomarkers Prev 1998; 7: 283-290.
47. STAHL W, SIES H. Lycopene: A biologically important carotenoid for humans? Arch Biochem Biophys 1996; 336: 1-9.
48. NGUYEN ML, SCHWARTZ SJ. Lycopene: Chemical and biological properties. Food Technol 1999; 53: 38-45.
49. KRINSKY NI, JOHNSON EJ. Carotenoid actions and their relation to health disease. Mol Aspects Med 2005; 26: 459-516.
50. ZHANG LX, COONEY RV, BERTRAM JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: Relationship to their cancer chemopreventive action. Carcinogenesis 1991; 12: 2109-2114.
51. ZHANG LX, COONEY RV, BERTRAM JS. Carotenoids upregulate connexin43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res 1992; 52: 5707-5712.
52. WITZTUM JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
53. WITZTUM JL. Role of oxidized low densirty lipoprotein in atherogenesis. Br Heart J 1993; 69: S12-S18.
54. FREI B. Cardiovascular disease and nutrient antioxidants: Role of low-density lipoprotein oxidation. Crit Rev Food Sci Nutr 1995; 351: 83-98.
55. HOLVOET P, COLLEN D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 1994; 8: 1279-1284.
56. FUHRAMN B, ELIS A, AVIRAM M. Hypocholesterolemic effect of lycopene and β-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophage. Biochem Biophys Res Commun 1997; 233: 658-662.
57. AGARWAL S, RAO AV. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study. Lipids 1998; 33: 981-984.
58. RAO AV, AGARWAL S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 1998; 31: 199-203.
59. POOL-ZOBEL BL, BUB A, MULLER H, WOLLOWSKI J, RECHKEMMER G. Consumption of vegetables reduces genetic damage in humans: First result of a human intervention trial with carotenoid-rich foods. Carcinogenesis 1997; 18: 1847-1850.
60. RAO AV, AGARWAL S. Effect of diet and smoking on serum lycopene and lipid peroxidation. Nutr Res 1998; 18: 713-721.
61. KOHLMEIER L, KARK JD, GOMEZ-GARCIA E, MARTIN BC, STECK SE, KARDINAL AFM. Lycopene and miocardial infarction risk in the EURAMIC study. Am J Epidemiol 1997; 146: 618-626.
62. AGARWAL S, RAO AV. Carotenoids and chronic disease. Drug Metabol Drug Interact 2000; 17: 189-209.
63. ZOCK P, KATAN MB. Diet, LDL oxidation, and coronary artery disease. Am J Clin Nutr 1998; 68: 759-760.
64. SESSO HD, BURING JE, NORKUS EP, GAZIANO JM. Plasma lycopene, other carotenoids, retinol and the risk of cardiovascular disease in men. Am J Clin Nutr 2005; 81: 990-997.
65. HOZAWA A, JACOBS DR, STEFFES MW, GROSS MD, STEFFEN LM, LEE DH. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study. Clin Chem 2007; 53: 447-455.
66. LIDEBJER C, LEANDERSON P, ERNERUDH J, JONASSON L. Low plasma levels of oxygenated carotenoids in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 2007; 17: 448-456.
67. HANDELMAN GJ, PARKER L, CROSS CE. Destruction of tocopherols, carotenoids and retinol in human plasma by cigarette smoke. Am J Clin Nutr 1996; 63: 559-565.
68. KRISTENSON M, ZIEDEN B, KUCINSKIENE Z, ELINDER LS, BERGDAHL B, ELWING B. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: Concomitant cross sectional study of men aged 50. Br Med J 1997; 314: 629-633.
69. ITO Y, KURATA M, SUZUKI K, HAMAJIMA N, HISHIDA H, AOKI K. Cardiovascular disease mortality and serum carotenoid levels: A Japanese population-based follow-up study. J Epidemiol 2006; 16: 154-160.
70. IRRIBARREN C, FOLSON AR, JACOBS DR, CROSS MD, BELCHER JD, ECKFELDT JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 1171-1177.
71. BOSE KS, AGRAWAL BK. Effect of lycopene from cooked tomatoes on serum antioxidant enzymes, lipid peroxidation rate and lipide profile in coronary heart disease. Singapore Med J 2007; 48: 415-420.
72. VISIOLI F, RISO P, GRANDE S, GALLI C, PORRINI M. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr 2003; 42: 201-206.
73. FUHRMAN B, ELIS A, AVIRAM M. Hypercholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophage. Biochem Biophys Res Commun 1997; 233: 658-662.
74. RAO AV, AGARWAL S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 1998; 31: 199-203.
75. AGARWAL S, RAO AV. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study. Lipids 1988; 33: 981-984.
76. PATERSON E, GORDON MH, NIWAT C, GEORGE PARR L, WAROONPHAN S, LOVEGROVE JA. Supplementation with fruit and vegetable soups and beverages increas plasma carotenoid concentrations but does not alter marker of oxidative stress or cardiovascular risk factors. J Nutr 2006; 136: 2849-2855.
77. VOUTILAINEN S, NURMI T, MURSU U, RISSANEN TH. Carotenoids and cardiovascular health. Am J Clin Nutr 2006; 83: 1265-1271.
78. SESSO HD. Carotenoids and cardiovascular disease: What research gaps remain? Curr Opin Lipidol 2006; 17: 11-16.
79. DAS S, OTANI H, MAULIK N, DAS DH. Lycopene, tomatoes, and coronary heart disease. Free Rad Res 2005; 39: 449-455.
80. KAUORA AC, DEDOUSSIS GV, SCHMIDT H. Dietary antioxidants in preventing atherogenesis. Atherosclerosis 2006; 187: 1-17.